![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CTRB1 |
Gene summary for CTRB1 |
![]() |
Gene information | Species | Human | Gene symbol | CTRB1 | Gene ID | 1504 |
Gene name | chymotrypsinogen B1 | |
Gene Alias | CTRB | |
Cytomap | 16q23.1 | |
Gene Type | protein-coding | GO ID | GO:0006508 | UniProtAcc | P17538 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
1504 | CTRB1 | HTA12-15-2 | Human | Pancreas | PDAC | 2.63e-53 | -2.66e+00 | 0.2315 |
1504 | CTRB1 | HTA12-16-5 | Human | Pancreas | PDAC | 5.55e-03 | -9.31e-02 | 0.047 |
1504 | CTRB1 | HTA12-23-1 | Human | Pancreas | PDAC | 9.09e-39 | -2.66e+00 | 0.3405 |
1504 | CTRB1 | HTA12-25-1 | Human | Pancreas | PDAC | 2.08e-52 | -2.66e+00 | 0.313 |
1504 | CTRB1 | HTA12-26-1 | Human | Pancreas | PDAC | 7.53e-62 | -2.66e+00 | 0.3728 |
1504 | CTRB1 | HTA12-29-1 | Human | Pancreas | PDAC | 2.80e-133 | -2.66e+00 | 0.3722 |
1504 | CTRB1 | HTA12-3-16 | Human | Pancreas | PDAC | 2.87e-15 | -2.66e+00 | 0.1553 |
1504 | CTRB1 | HTA12-30-1 | Human | Pancreas | PDAC | 9.52e-17 | -2.66e+00 | 0.3671 |
1504 | CTRB1 | HTA12-32-1 | Human | Pancreas | PDAC | 1.76e-23 | -2.40e+00 | 0.3624 |
1504 | CTRB1 | HTA12-9-1 | Human | Pancreas | PDAC | 6.05e-78 | -2.46e+00 | 0.1532 |
1504 | CTRB1 | HTA12-9-2 | Human | Pancreas | PDAC | 1.28e-18 | -2.85e-01 | 0.0835 |
1504 | CTRB1 | HTA12-9-3 | Human | Pancreas | PDAC | 7.05e-45 | -2.66e+00 | 0.2045 |
1504 | CTRB1 | 4347-EC | Human | Pancreas | PanIN | 4.14e-46 | -2.09e-01 | 0.0572 |
1504 | CTRB1 | 4741-EC2 | Human | Pancreas | PanIN | 8.44e-24 | 9.84e-02 | 0.0194 |
1504 | CTRB1 | 181429 | Human | Pancreas | PDAC | 3.62e-26 | -2.66e+00 | 0.1416 |
1504 | CTRB1 | 61354830 | Human | Pancreas | PDAC | 9.52e-17 | -2.66e+00 | 0.1458 |
1504 | CTRB1 | DS20191261Tumor | Human | Pancreas | PDAC | 1.09e-92 | -2.66e+00 | 0.1367 |
1504 | CTRB1 | DS20191261TumorKeller | Human | Pancreas | PDAC | 3.69e-32 | -2.66e+00 | 0.1407 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Cervix | N_HPV | ![]() |
Endometrium | AEH | ![]() |
Endometrium | EEC | ![]() |
Prostate | BPH | ![]() |
Prostate | Tumor | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |